Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERTâ„¢ platform. In return, ...
With the economy a key factor in German elections this month, can the auto sector get back on the road to recovery?